Literature Collection

Collection Insights

10K+

References

9K+

Articles

1400+

Grey Literature

4500+

Opioids & SU

The Literature Collection contains over 10,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
677 Results
581
The development of an Opiate Withdrawal Scale (OWS)
Type: Journal Article
Authors: B. P. Bradley, M. Gossop, G. T. Phillips, J. J. Legarda
Year: 1987
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
582
The Dual Diagnosis Physician-infrastructure Assessment Tool: Examining physician attributes and dual diagnosis capacity
Type: Journal Article
Authors: Andrew Chambers, Michael C. Connor, Cathy J. Boggs, George F. Parker
Year: 2010
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
,
Measures See topic collection
583
The Effect of Integrating Primary Care and Mental Health Services on Diabetes and Depression: A Multi-site Impact Evaluation on the US-Mexico Border
Type: Journal Article
Authors: L. S. Wolff, A. Flynn, Z. Xuan, K. S. Errichetti, Tapia Walker, M. K. Brodesky
Year: 2021
Publication Place: United States
Abstract:

BACKGROUND: Health care delivery systems are increasingly integrating physical and mental health services to address patients' complex needs, contain costs, and improve satisfaction. Therefore, it is critical to understand whether adoption of integrated care models is effective in diverse settings. OBJECTIVE: This study examined the effect of integrated care on physical and mental health outcomes among low-income Latino participants on the US-Mexico border. RESEARCH DESIGN: In this quasi-experimental multisite study, individual-level data were pooled from 8 studies of locally adapted integrated care models. SUBJECTS: Participants were 18 years or older and had 1 or more chronic conditions: diabetes, depression, hypertension, or obesity. The study enrolled 4226 participants with 2254 participants in the intervention group and 1972 in the comparison group. MEASURES: Primary outcomes were depressive symptoms as measured by the Patient Health Questionnaire-9 score and blood glucose measured by hemoglobin A1c (HbA1c). Blood pressure, body mass index, and quality of life were secondary outcomes. RESULTS: Multivariable linear regression analyses indicated intervention participants had significantly lower Patient Health Questionnaire-9 scores (β=-0.39, P=0.03) and HbA1c (β=-0.14, P=0.02) at 12 months compared with comparison group participants. Stratified analyses showed improvements in HbA1c were even greater among intervention participants who had diabetes, depression, severe and persistent mental illness, were older or female compared with their counterparts in the comparison group. CONCLUSIONS: Health care is constantly transforming, making it critical to study these changes across populations and settings. Findings from this study indicate that integrated care can significantly improve mental and physical health in an underserved Latino population.

Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
584
The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III
Type: Journal Article
Authors: Ahmed N. Hassan, Bernard Le Foll, Sameer Imtiaz, Jurgen Rehm
Year: 2017
Publication Place: Lausanne
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
,
Opioids & Substance Use See topic collection
585
The effectiveness of a primary care-based collaborative care model to improve quality of life in people with severe mental illness: PARTNERS2 cluster randomised controlled trial
Type: Journal Article
Authors: R. Byng, S. Creanor, B. Jones, J. Hosking, H. Plappert, S. Bevan, N. Britten, M. Clark, L. Davies, J. Frost, L. Gask, B. Gibbons, J. Gibson, P. Hardy, C. Hobson-Merrett, P. Huxley, A. Jeffery, S. Marwaha, T. Rawcliffe, S. Reilly, D. Richards, R. Sayers, L. Williams, V. Pinfold, M. Birchwood
Year: 2023
Abstract:

BACKGROUND: Individuals living with severe mental illness can have significant emotional, physical and social challenges. Collaborative care combines clinical and organisational components. AIMS: We tested whether a primary care-based collaborative care model (PARTNERS) would improve quality of life for people with diagnoses of schizophrenia, bipolar disorder or other psychoses, compared with usual care. METHOD: We conducted a general practice-based, cluster randomised controlled superiority trial. Practices were recruited from four English regions and allocated (1:1) to intervention or control. Individuals receiving limited input in secondary care or who were under primary care only were eligible. The 12-month PARTNERS intervention incorporated person-centred coaching support and liaison work. The primary outcome was quality of life as measured by the Manchester Short Assessment of Quality of Life (MANSA). RESULTS: We allocated 39 general practices, with 198 participants, to the PARTNERS intervention (20 practices, 116 participants) or control (19 practices, 82 participants). Primary outcome data were available for 99 (85.3%) intervention and 71 (86.6%) control participants. Mean change in overall MANSA score did not differ between the groups (intervention: 0.25, s.d. 0.73; control: 0.21, s.d. 0.86; estimated fully adjusted between-group difference 0.03, 95% CI -0.25 to 0.31; P = 0.819). Acute mental health episodes (safety outcome) included three crises in the intervention group and four in the control group. CONCLUSIONS: There was no evidence of a difference in quality of life, as measured with the MANSA, between those receiving the PARTNERS intervention and usual care. Shifting care to primary care was not associated with increased adverse outcomes.

Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
586
The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial
Type: Journal Article
Authors: J. Ahmadi, M. S. Jahromi, Z. Ehsaei
Year: 2018
Publication Place: England
Abstract: BACKGROUND: Buprenorphine is usually administered to treat opioid use disorder and pain syndromes. This research presents the first study regarding the effectiveness of different singly administered high doses of buprenorphine (a partial opioid agonist (of mu-opioid receptors), a potent opioid antagonist (of kappa-receptors) and a partial agonist of nociception receptors) in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence. It follows small studies that suggest that ultra-low-dose buprenorphine may be useful in reducing suicidal ideation. The goal of this study was to describe the outcome of different doses of buprenorphine on suicidal opioid-dependent patients over a 3-day interval, by conducting a randomized clinical trial. METHODS: Fifty-one suicidal male inpatients who fulfilled the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for both opioid dependence and major depressive disorder were randomized to three groups (n = 17 per group) to receive a single, sublingual dose of buprenorphine (32 mg, 64 mg, or 96 mg). Out of 51 participants, there were 47 patients; 16 (34.04%) received 32 mg, 17 (36.17%) received 64 mg, and 14 (29.78%) received 96 mg of sublingual buprenorphine. They were evaluated by using psychometric assessment of the Beck Scale for Suicidal Ideation (BSSI) and interviews based on DSM-5 criteria. A placebo group was not included because of the high probability of severe withdrawal without active pharmacological treatment. The study was conducted with appropriate precautions and monitoring of respiratory and cardiovascular measures. The medication was administered while the patients were in moderate opiate withdrawal, as indicated by the presence of four to five withdrawal symptoms. A structured clinical interview was conducted, and urine toxicology testing was performed. RESULTS: Patients completed the 3-day trial course. The outcomes illustrated a significant reduction in BSSI scores within each of the three groups, p < 0.01., but no difference in results between the groups, p = 0.408. CONCLUSIONS: The results suggest that a single high dose of buprenorphine could rapidly treat suicidal ideations. A single high dose of buprenorphine may be a main-mechanism medication that gives a rapid treatment for suicidal opioid-dependent patients. Placebo-controlled trials are required to measure the safety and the physiological and psychological effects of this medication.
Topic(s):
Measures See topic collection
,
Opioids & Substance Use See topic collection
589
The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A Bayesian mediation analysis
Type: Journal Article
Authors: Joy M. Schmitz, Robert Suchting, Charles E. Green, Heather E. Webber, Jessica Vincent, F. G. Moeller, Scott D. Lane
Year: 2021
Topic(s):
Measures See topic collection
,
Opioids & Substance Use See topic collection
590
The Effects of Interpreter Use on Agreement Between Clinician- and Self-Ratings of Functioning in Hispanic Integrated Care Patients
Type: Journal Article
Authors: Aubrey R. Dueweke, Ana J. Bridges, Debbie P. Gomez
Year: 2016
Publication Place: New York
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
591
The efficacy of a systematic substance abuse program for adolescent females (Drug Use Knowledge Examination)
Type: Journal Article
Authors: J. G. Froeschle, R. L. Smith, R. Ricard
Year: 2007
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
593
The family check-up in a pediatric clinic: An integrated care delivery model to improve behaviors in the home environment
Type: Journal Article
Authors: Courtney Smith, Karen E. Schetzina, Jodi Polaha, Katie Baker, David Wood
Year: 2016
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
594
The Five S's: A Communication Tool for Child Psychiatric Access Projects
Type: Journal Article
Authors: J. Harrison, K. Wasserman, J. Steinberg, R. Platt, K. Coble, K. Bower
Year: 2016
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection
596
The Impact of Systematic Depression Screening in Primary Care on Depression Identification and Treatment in a Large Health Care System: A Cohort Study
Type: Journal Article
Authors: E. R. Pfoh, I. Janmey, A. Anand, K. A. Martinez, I. Katzan, M. B. Rothberg
Year: 2020
Abstract:

BACKGROUND: Unless implementation of systematic depression screening is associated with timely treatment, quality measures based on screening are unlikely to improve outcomes. OBJECTIVE: To assess the impact of integrating systematic depression screening with clinical decision support on depression identification and treatment. DESIGN: Retrospective pre-post study. PARTICIPANTS: Adults with a primary care visit within a large integrated health system in 2016 were included. Adults diagnosed with depression in 2015 or prior to their initial primary care visit in 2016 were excluded. INTERVENTION: Initiation of systematic screening using the Patient Health Questionnaire (PHQ) which began in mid-2016. MAIN MEASURES: Depression diagnosis was based on ICD codes. Treatment was defined as (1) antidepressant prescription, (2) referral, or (3) evaluation by a behavioral health specialist. We used an adjusted linear regression model to identify whether the percentage of visits with a depression diagnosis was different before versus after implementation of systematic screening. An adjusted multilevel regression model was used to evaluate the association between screening and odds of treatment. KEY RESULTS: Our study population included 259,411 patients. After implementation, 59% of patients underwent screening. Three percent scored as having moderate to severe depression. The rate of depression diagnosis increased by 1.2% immediately after systematic screening (from 1.7 to 2.9%). The percent of patients with diagnosed depression who received treatment within 90 days increased from 64% before to 69% after implementation (p < 0.01) and the adjusted odds of treatment increased by 20% after implementation (AOR 1.20, 95% CI 1.12-1.28, p < 0.01). CONCLUSIONS: Implementing systematic depression screening within a large health care system led to high rates of screening and increased rates of depression diagnosis and treatment.

Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
597
The importance of social risk factors for patients diagnosed with opioid use disorder
Type: Journal Article
Authors: C. Arsene, L. Na, P. Patel, V. Vaidya, A. A. Williamson, S. Singh
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection
598
The integrated care performance assessment tool: a co-design approach
Type: Journal Article
Authors: Mariana Dates, Micol Tedeschi, Niamh Lennox-Chhugani
Year: 2019
Topic(s):
Education & Workforce See topic collection
,
Measures See topic collection